1986
DOI: 10.1016/0028-2243(86)90173-5
|View full text |Cite
|
Sign up to set email alerts
|

Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1989
1989
2002
2002

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…The operative castration and subsequent hypoestrogenis m would be the real solution in the treatment of the disease, but it is out of the question with young women of reproductive age. The development of GnRH analogs, which reversibly inhibit the function of the ovary in a hormonal way, was a breakthrough in the treatment of the disease [4,11]. The e ects of the hormones employed in the treatment of endometriosis are listed in Table 3.…”
Section: Discussionmentioning
confidence: 99%
“…The operative castration and subsequent hypoestrogenis m would be the real solution in the treatment of the disease, but it is out of the question with young women of reproductive age. The development of GnRH analogs, which reversibly inhibit the function of the ovary in a hormonal way, was a breakthrough in the treatment of the disease [4,11]. The e ects of the hormones employed in the treatment of endometriosis are listed in Table 3.…”
Section: Discussionmentioning
confidence: 99%